[关键词]
[摘要]
高度近视矫治一直是眼科临床的挑战。有晶状体眼后房型人工晶状体(ICL)植入术已成为高度近视患者的主要治疗选择。近年来的研究表明，ICL植入术不仅有效矫正中高度近视，也逐渐应用于中低度近视。此外，ICL植入术还可解决一些困难的屈光问题，并可与角膜屈光手术结合，扩大矫正范围。ICL植入术具有矫正度数范围广、术后视觉质量好、可预测性强、可逆性及保留患者自身晶状体调节能力等优点，在临床上逐步显现出独特的优越性。术后并发性白内障是常见的影响视力因素，严重者需要进行二次手术。ICL植入术后并发性白内障的发生机制与ICL的设计、材质、拱高及患者自身因素等有关。文章旨在综述ICL设计的更新迭代、术后并发性白内障的机制及其防治。
[Key word]
[Abstract]
Correcting high myopia has always been challenging in clinical practice. For patients with high myopia, the implantation of an implantable collamer lens(ICL)has become the main treatment option. Recent studies have shown that ICL implantation is effective not only for correcting moderate-to-high myopia but is also increasingly used for mild-to-moderate myopia. Furthermore, ICL implantation can address difficult refractive problems and can be combined with corneal refractive surgery to extend the range of correction. ICL implantation offers a wide range of corrections, good postoperative visual quality, high predictability, reversibility, and preservation of the natural accommodative capacity. It is gradually demonstrating its unique advantages in clinical practice. Postoperative complicated cataract is a common cause of visual impairment, and severe cases may require secondary surgery. The design, material, and vault of the ICL, along with patient-specific factors, are related to the mechanism of postoperative complicated cataracts after ICL implantation. The purpose of this article is to review the updates and iterations in ICL design, the mechanism of postoperative complicated cataracts, and their prevention.
[中图分类号]
[基金项目]
国家自然科学基金资助项目(No.U2267220)
